Tempus, Inc.

Enabling precision medicine at scale by deriving insights and facilitating discovery through real-world matched clinical and molecular datasets.

See Tempus COO, Ryan Fukushima present on Leveraging Multi-modal Data for Precision Medicine on November 9 at 11:10 am GMT+2.

See Jonathan Dry, Vice President of Scientific Discovery present on advances and impact of data science for oncology research and early development at Tempus on November 11 at 1:10 pm GMT+2

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With the of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitate discovery, development and delivery of optimized therapeutic options for patients through distinctive solution sets. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.